Furafylline
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
3-(furan-2-ylmethyl)-1,8-dimethyl-7H-purine-2,6-dione | |
| Identifiers | |
| CAS Number |
80288-49-9 |
| PubChem | CID 3433 |
| UNII |
C2087G0XX3 |
| ChEMBL |
CHEMBL372638 |
| Chemical data | |
| Formula | C12H12N4O3 |
| Molar mass | 260.25 g/mol |
| | |
Furafylline is a methylxanthine derivative that was introduced in hope of being a long-acting replacement for theophylline in the treatment of asthma.[1] It is an inhibitor of CYP1A2.[1]
References
- 1 2 Sesardic, D.; Boobis, A. R.; Murray, B. P.; Murray, S.; Segura, J.; De La Torre, R.; Davies, D. S. (1990). "Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man". British Journal of Clinical Pharmacology 29 (6): 651–663. doi:10.1111/j.1365-2125.1990.tb03686.x. PMC 1380167. PMID 2378786.
This article is issued from Wikipedia - version of the Wednesday, September 02, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
